Form 8-K - Current report:
SEC Accession No. 0001193125-18-124970
Filing Date
2018-04-20
Accepted
2018-04-20 16:31:03
Documents
3
Period of Report
2018-04-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d535814d8k.htm 8-K 19602
2 EX-10.1 d535814dex101.htm EX-10.1 15080
3 GRAPHIC g535814g0420122531364.jpg GRAPHIC 5244
  Complete submission text file 0001193125-18-124970.txt   43608
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 18767098
SIC: 2834 Pharmaceutical Preparations